Tarsus Pharmaceuticals, Inc.
TARS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001819790
In the last 90 days, Tarsus Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 256 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; no superinvestor holds it.
Holders of 5% or more of TARS
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Tarsus Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Deep Track Capital, LP | 13G/A | 8.46%3.60M shares | +1.35 ppfrom 7.11% | Jul 28, 20253 filings | May 15, 2026 | SEC |
| RTW Investments, LP | 13G/A | 8.10%3.42M shares | – | Feb 12, 20215 filings | Aug 14, 2025 | SEC |
| BlackRock, Inc. | 13G/A | 7.40%3.09M shares | – | Oct 21, 20243 filings | Apr 24, 2025 | SEC |
| Janus Henderson Group PLC | 13G/A | 6.50%2.81M shares | +1.20 ppfrom 5.30% | May 15, 20262 filings | Aug 13, 2026 | SEC |
| FMR LLC | 13G | 6.40%3.14M shares | New | Nov 5, 20261 filing | Nov 5, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
58 Schedule 13D and 13G filings on Tarsus Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 5, 20261:27 PM ET | FMR LLCand 1 other | 13G | 6.40%3.14M shares | New | Sep 30, 2026 | SEC |
| Aug 13, 202612:47 PM ET | Janus Henderson Group PLC | 13G/A | 6.50%2.81M shares | +1.20 ppfrom 5.30% | Jun 30, 2026 | SEC |
| May 15, 202611:43 AM ET | Janus Henderson Group PLC | 13G | 5.30%2.24M shares | New | Mar 31, 2026 | SEC |
| May 15, 20268:46 AM ET | Deep Track Capital, LPand 2 others | 13G/A | 8.46%3.60M shares | +1.35 ppfrom 7.11% | Mar 31, 2026 | SEC |
| May 8, 202611:21 AM ET | Prudential Financial Inc | 13G/A | 4.30%1.84M shares | –Below 5% | Mar 31, 2026 | SEC |
| May 6, 20264:13 PM ET | Jennison Associates LLC | 13G/A | 4.00%1.71M shares | –Below 5% | Mar 31, 2026 | SEC |
| Mar 27, 20261:34 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Feb 17, 20264:15 PM ET | Tang Capital Management LLCand 5 others | 13G/A | 2.80%1.19M shares | −3.10 ppfrom 5.90%Below 5% | Dec 31, 2025 | SEC |
| Nov 14, 20258:23 AM ET | Deep Track Capital, LPand 2 others | 13G/A | 7.11%3.00M shares | +1.51 ppfrom 5.60% | Sep 30, 2025 | SEC |
| Aug 14, 20258:08 AM ET | RTW Investments, LPand 1 other | 13G/A | 8.10%3.42M shares | – | Jun 30, 2025 | SEC |
| Jul 28, 20255:00 PM ET | Deep Track Capital, LPand 2 others | 13G | 5.60%2.35M shares | New | Jul 21, 2025 | SEC |
| May 15, 20254:15 PM ET | Tang Capital Management LLCand 5 others | 13G/A | 5.90%2.45M shares | – | Mar 31, 2025 | SEC |
| May 7, 202511:27 AM ET | Morgan Stanley | 13G/A | 4.70%1.94M shares | –Below 5% | Mar 31, 2025 | SEC |
| Apr 24, 20259:12 AM ET | BlackRock, Inc. | 13G/A | 7.40%3.09M shares | – | Mar 31, 2025 | SEC |
| Feb 13, 202512:22 PM ET | Cowen Financial Products LLC | 13G/A | 4.90%1.91M shares | –Below 5% | Dec 31, 2024 | SEC |
| Nov 14, 2024 | Cormorant Asset Management, LP | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Prudential Financial Inc | 13GOld format | – | New | – | SEC |
| Nov 14, 2024 | Paradigm Biocapital Advisors LP | 13G/AOld format | – | – | – | SEC |
| Nov 12, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Nov 12, 2024 | Jennison Associates LLC | 13GOld format | – | New | – | SEC |
| Nov 8, 2024 | BlackRock, Inc. | 13G/AOld format | – | – | – | SEC |
| Nov 6, 2024 | Frazier Life Sciences IX, L.P. | 13G/AOld format | – | – | – | SEC |
| Nov 4, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Oct 21, 2024 | BlackRock, Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Tang Capital Partners LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Cormorant Asset Management, LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | RTW Investments, LP | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Vivo Capital IX, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | Morgan Stanley | 13GOld format | – | New | – | SEC |
| Feb 2, 2024 | TimesSquare Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 2, 2024 | Cowen Financial Products LLC | 13G/AOld format | – | – | – | SEC |
| Jan 26, 202411:49 AM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Jan 22, 2024 | Paradigm Biocapital Advisors LP | 13GOld format | – | New | – | SEC |
| May 5, 2023 | Cowen Financial Products LLC | 13GOld format | – | New | – | SEC |
| Feb 14, 2023 | Tang Capital Partners LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Vivo Capital IX, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Perceptive Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Cormorant Asset Management, LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | RTW Investments, LP | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2023 | Flynn James E | 13G/AOld format | – | – | – | SEC |
| Feb 9, 202311:01 AM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Feb 8, 20231:16 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
| Feb 3, 2023 | TimesSquare Capital Management, LLC | 13GOld format | – | New | – | SEC |
| May 13, 2022 | Tang Capital Partners LP | 13GOld format | – | New | – | SEC |
| May 11, 2022 | Flynn James E | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | Perceptive Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Azamian Bobak R. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Ackermann Michael | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Cormorant Asset Management, LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | RTW Investments, LP | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
118 notices from officers, directors and other affiliates planning to sell Tarsus Pharmaceuticals, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Sep 15, 20264:51 PM ET | William J LinkDirector | 12.5K | $979.7K | Sep 15, 202610b5-1 | MERRILL LYNCH | SEC |
| Sep 4, 20265:23 PM ET | Bobak AzamianOfficer | 10.0K | $905.6K | Sep 4, 202610b5-1 | MERRILL LYNCH | SEC |
| Sep 4, 20264:03 PM ET | Lin Elizabeth YeuFamily member of an insider | 3.18K | $278.3K | Sep 4, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Sep 4, 20263:59 PM ET | Lin Elizabeth YeuOfficer | 10.8K | $942.6K | Sep 4, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Sep 4, 20263:36 PM ET | Neervannan SeshadriOfficer | 4.56K | $387.9K | Sep 4, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Sep 2, 20264:31 PM ET | Lin Elizabeth YeuFamily member of an insider | 1.59K | $127.2K | Sep 2, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Sep 2, 20263:40 PM ET | Mottiwala AzizFormer officer | 8.00K | $654.4K | Sep 2, 2026 | Fidelity Brokerage Services LLC | SEC |
| Sep 2, 20263:38 PM ET | Lin Elizabeth YeuOfficer | 5.39K | $431.0K | Sep 2, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Sep 2, 20262:39 PM ET | Bobak AzamianOfficer | 10.0K | $800.6K | Sep 2, 202610b5-1 | MERRILL LYNCH | SEC |
| Sep 1, 20264:09 PM ET | Mottiwala AzizFormer officer | 77.7K | $5.75M | Sep 1, 2026 | Fidelity Brokerage Services LLC | SEC |
| Sep 1, 20262:23 PM ET | Lin Elizabeth YeuOfficer | 4.60K | $339.8K | Sep 1, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Aug 25, 20264:19 PM ET | Mottiwala AzizFormer officer | 81.3K | $5.84M | Aug 25, 2026 | Fidelity Brokerage Services LLC | SEC |
| Aug 19, 20262:27 PM ET | Mottiwala AzizFormer officer | 53.0K | $3.82M | Aug 19, 2026 | Fidelity Brokerage Services LLC | SEC |
| Jun 17, 20262:05 PM ET | Bobak AzamianOfficer | 10.0K | $615.5K | Jun 17, 202610b5-1 | MERRILL LYNCH | SEC |
| Jun 16, 20264:53 PM ET | Farrow Jeffrey SOfficer | 14.4K | $877.5K | Jun 16, 2026 | Fidelity Brokerage Services LLC | SEC |
| Jun 15, 20264:58 PM ET | William J LinkDirector | 12.5K | $776.5K | Jun 15, 202610b5-1 | Merrill Lynch | SEC |
| Jun 15, 202611:44 AM ET | Goodrich KatherineDirector | 2.95K | $183.4K | Jun 15, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Mar 20, 202610:38 AM ET | Neervannan SeshadriOfficer | 2.99K | $199.5K | Mar 20, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Mar 19, 20264:43 PM ET | Farrow Jeffrey SOfficer | 2.19K | $146.5K | Mar 19, 2026 | Fidelity Brokerage Services LLC | SEC |
| Mar 19, 20264:38 PM ET | Mottiwala AzizOfficer | 4.44K | $297.5K | Mar 19, 2026 | Fidelity Brokerage Services LLC | SEC |
| Mar 19, 20264:30 PM ET | Azamian Bobak R.Officer · Director | 12.0K | $801.6K | Mar 19, 2026 | Fidelity Brokerage Services LLC | SEC |
| Mar 19, 20264:24 PM ET | Whitfield Dianne C.Officer | 4.17K | $279.7K | Mar 19, 2026 | Fidelity Brokerage Services LLC | SEC |
| Mar 19, 20264:23 PM ET | Wahl BryanOfficer | 4.23K | $283.5K | Mar 19, 2026 | Fidelity Brokerage Services LLC | SEC |
| Mar 19, 20264:15 PM ET | Neervannan SeshadriOfficer | 4.59K | $307.5K | Mar 19, 2026 | Fidelity Brokerage Services LLC | SEC |
| Mar 19, 20264:14 PM ET | Lin Elizabeth YeuOfficer | 390 | $26.1K | Mar 19, 2026 | Fidelity Brokerage Services LLC | SEC |
Showing the latest 25. See the TARS notices from the last 12 months